Clinical trial
Intramyocardial Injection of Autologous Aldehyde Dehydrogenase-Bright Stem Cells…
NCT00314366 · Texas Heart Institute, Other · Completed
Key facts
| NCT number | NCT00314366 |
|---|---|
| Title | Intramyocardial Injection of Autologous Aldehyde Dehydrogenase-Bright Stem Cells for Therapeutic Angiogenesis (FOCUS Br) |
| Official title | Phase IB Randomized Controlled Double-Blind Trial of Intramyocardial Injection of Autologous Aldehyde Dehydrogenase-Bright Stem Cells Under Electromechanical Guidance for Therapeutic Angiogenesis |
| Lead sponsor | Texas Heart Institute, Other |
| Collaborators | CHI St. Luke's Health, Texas Aldagen Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Coronary Artery Disease |
| Intervention type | Biological, Other |
| Interventions | Stem Cell Therapy, Control (plasma) |
| Enrollment | 21 |
| Start date | Apr 1, 2006 |
| Primary completion | Aug 1, 2009 |
| Completion | Aug 24, 2023 |
| First posted | Apr 13, 2006 |
| Last update posted | Apr 23, 2024 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: